經導管心臟瓣膜置換術 (THVR) 的全球市場（2023-2030）：按產品和手術方法分類的規模、佔有率、成長分析和預測

Global Transcatheter Heart Valve Replacement Market Size, Share, Growth Analysis, By Product, By Surgical Approach - Industry Forecast 2023-2030

出版日期: 2023年09月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球經導管心臟瓣膜置換術（THVR）市場規模預計將從2021年的53.3億美元成長到2022年的57.1億美元，預測期內年複合成長率為7.2%，到2030年預計將成長到美國106.8億美元。

由於技術進步、人口高齡化和心血管疾病的增加，THVR 市場正在經歷顯著成長。與傳統的心臟直視手術相比，經導管技術降低了手術風險並縮短了恢復時間。市場領先的公司不斷創新，使其設備更加耐用，並將其適用性擴展到更廣泛的患者群體。市場擴張也得益於意識的提高、有利的報銷政策以及醫療保健專業人員和製造商之間的合作配合措施。

市場趨勢

技術進步和創新正在再形成THVR 市場形勢。這些進步使得先進的、侵入性較小的手術成為可能。顯著的增強包括複雜的閥門結構、升級的影像模式和新穎的輸送機制。這一演變最大限度地減少了併發症，擴大了可治療的患者範圍，並支持了將 THVR 作為解決主動脈瓣疾病最佳方法的趨勢。

本報告調查了全球經導管心臟瓣膜置換術（THVR）市場，提供了市場概況，分析了市場上的各種影響因素、技術和創新趨勢、法律制度、市場規模趨勢和預測，並提供了各種資訊。總結了按類別和地區分類的細分、競爭形勢以及主要企業的概況。

市場概況
市場規模
市場動態
- 促進因素
- 機會
- 抑制因素
- 任務
關鍵市場洞察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- 啟動分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 重點投資分析
- 關鍵成功要素
- 競爭程度
市場動態及前景
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 任務
- 法規狀況
- 波特的分析
- Skyquest 對未來顛覆的獨家見解
全球經導管心臟瓣膜置換術 (THVR) 市場：按產品
- 市場概況
- 經導管主動脈瓣置換術
- 經導管二尖瓣修復/替換
- 經導管肺動脈瓣置換術
全球經導管心臟瓣膜置換術 (THVR) 市場：依手術方法分類
- 市場概況
- 經股動脈路徑
- 經心尖入路
- 經主動脈入路
全球經導管心臟瓣膜置換術（THVR）市場（按地區）
- 市場概況
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東/非洲
競爭形勢
- 前5名企業對比
- 主要企業市場地位
- 主要企業的招募策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率
- 主要企業簡介
- 4C Medical Technologies
- Abbott
- Boston Scientific
- Edwards Lifesciences
- HighLife Medical
- JC Medical
- LivaNova
- Medtronic plc
- Neovasc - Canada

簡介目錄

Product Code: SQMIG35D2143

Market Insights

Global Transcatheter Heart Valve Replacement Market size was valued at USD 5.33 billion in 2021 and is poised to grow from USD 5.71 billion in 2022 to USD 10.68 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The Global Transcatheter Heart Valve Replacement Market encompasses the medical sector focused on minimally invasive heart valve procedures. This market has witnessed significant growth due to advancements in technology, an aging population, and rising cardiovascular diseases. Transcatheter techniques offer reduced surgical risks and quicker recovery times compared to traditional open-heart surgeries. Leading market players are continually innovating to enhance device durability and expand application to a broader patient base. This market's expansion is driven by increased awareness, favorable reimbursement policies, and collaborative efforts between medical professionals and manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of transcatheter heart valve replacement and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segmental Analysis

The global transcatheter heart valve replacement market is segmented on the basis of product, surgical approach, application, end user, and region. By Product, the market is segmented into Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Repair and Replacement, and Transcatheter Pulmonary Valve Replacement. By Surgical approach, the market is segmented into Transfemoral Approach, Transapical Approach, and Transaortic Approach. By Application, the market is segmented into Aortic Valve Stenosis, Aortic Valve Regurgitation, Aortic Valvular Heart Disease, Mitral Valvular Heart Disease, Mitral Valve Regurgitation, Mitral Valve Stenosis, and Pulmonary Valvular Heart Disease. By End user, the market is segmented into Hospitals, and Cath labs. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers

Factors such as the aging global populace and the growing prevalence of heart valve conditions like aortic stenosis are fueling the need for transcatheter heart valve replacement (THVR). With extended lifespans, the chances of encountering valve-related ailments are higher, thus enlarging the pool of patients seeking THVR interventions.

Restraints

Substantial Initial Expenses and Reimbursement Constraints:

Commencing THVR procedures involves significant financial outlays, encompassing device acquisition and specialized apparatus. Furthermore, obstacles in reimbursement coupled with divergent healthcare regulations across geographical areas might impede patient admission and moderate market proliferation.

Market Trends

Technological progress and innovations are reshaping the landscape of the Transcatheter Heart Valve Replacement (THVR) market. These advancements are yielding sophisticated and less invasive procedures. Notable enhancements include refined valve configurations, upgraded imaging methods, and novel delivery mechanisms, collectively ensuring safer and more efficient interventions. This evolution minimizes complications, broadens the spectrum of suitable patients, and propels the preference for THVR as the optimal approach to address aortic valve conditions.